Global Cerebral Flow Diverter and Disruptor Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Cerebral Flow Diverter and Disruptor market size was valued at US$ 765 million in 2024 and is forecast to a readjusted size of USD 1337 million by 2031 with a CAGR of 8.4% during review period.
Compared with intra-aneurysmal flow disruptors, FDs have wider range of utility across aneurysms types, including ruptured, posterior circulation, nonsaccular, blister, anterior communicating, and pericallosal arteries, as well as utility in treating dissections and direct carotid-cavernous fistulas. For flow disruptors such as WEB, the range of aneurysms appropriate for treatment is narrower. The primary mechanism of efficacy for WEB is endosaccular disruption, which induces thrombogenesis within the dome and secondary flow diversion and neoendothelialization at the neck. Aneurysms for WEB should be wide-necked bifurcation aneurysms with a straight angle of approach for intrasaccular catheter placement. WEB cannot be successfully deployed in side wall aneurysms.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Cerebral Flow Diverter and Disruptor market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cerebral Flow Diverter and Disruptor market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cerebral Flow Diverter and Disruptor market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cerebral Flow Diverter and Disruptor market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cerebral Flow Diverter and Disruptor market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cerebral Flow Diverter and Disruptor
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cerebral Flow Diverter and Disruptor market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Balt, Stryker, MicroVention, Cerus Endovascular, Phenox GmbH, MicroPort NeuroTech, Skynor Medical, AccuMedical, NowYon Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cerebral Flow Diverter and Disruptor market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Flow Diverters
Endosaccular Disruptors
Market segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Major players covered
Medtronic
Balt
Stryker
MicroVention
Cerus Endovascular
Phenox GmbH
MicroPort NeuroTech
Skynor Medical
AccuMedical
NowYon Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cerebral Flow Diverter and Disruptor product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cerebral Flow Diverter and Disruptor, with price, sales quantity, revenue, and global market share of Cerebral Flow Diverter and Disruptor from 2020 to 2025.
Chapter 3, the Cerebral Flow Diverter and Disruptor competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cerebral Flow Diverter and Disruptor breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cerebral Flow Diverter and Disruptor market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cerebral Flow Diverter and Disruptor.
Chapter 14 and 15, to describe Cerebral Flow Diverter and Disruptor sales channel, distributors, customers, research findings and conclusion.
Compared with intra-aneurysmal flow disruptors, FDs have wider range of utility across aneurysms types, including ruptured, posterior circulation, nonsaccular, blister, anterior communicating, and pericallosal arteries, as well as utility in treating dissections and direct carotid-cavernous fistulas. For flow disruptors such as WEB, the range of aneurysms appropriate for treatment is narrower. The primary mechanism of efficacy for WEB is endosaccular disruption, which induces thrombogenesis within the dome and secondary flow diversion and neoendothelialization at the neck. Aneurysms for WEB should be wide-necked bifurcation aneurysms with a straight angle of approach for intrasaccular catheter placement. WEB cannot be successfully deployed in side wall aneurysms.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Cerebral Flow Diverter and Disruptor market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cerebral Flow Diverter and Disruptor market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cerebral Flow Diverter and Disruptor market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cerebral Flow Diverter and Disruptor market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cerebral Flow Diverter and Disruptor market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cerebral Flow Diverter and Disruptor
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cerebral Flow Diverter and Disruptor market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Balt, Stryker, MicroVention, Cerus Endovascular, Phenox GmbH, MicroPort NeuroTech, Skynor Medical, AccuMedical, NowYon Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cerebral Flow Diverter and Disruptor market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Flow Diverters
Endosaccular Disruptors
Market segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Major players covered
Medtronic
Balt
Stryker
MicroVention
Cerus Endovascular
Phenox GmbH
MicroPort NeuroTech
Skynor Medical
AccuMedical
NowYon Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cerebral Flow Diverter and Disruptor product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cerebral Flow Diverter and Disruptor, with price, sales quantity, revenue, and global market share of Cerebral Flow Diverter and Disruptor from 2020 to 2025.
Chapter 3, the Cerebral Flow Diverter and Disruptor competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cerebral Flow Diverter and Disruptor breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cerebral Flow Diverter and Disruptor market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cerebral Flow Diverter and Disruptor.
Chapter 14 and 15, to describe Cerebral Flow Diverter and Disruptor sales channel, distributors, customers, research findings and conclusion.
Table of Contents
104 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
